Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
20.03.26
/
50%
€28.40
Target price
20.03.27
€51.88
Performance (%)
0.95%
Price
07.04.26
€29.18
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc is nearly unchanged. This prediction currently runs until 20.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Stoke Therapeutics Inc | 4.964% |
| iShares Core DAX® | 2.554% |
| iShares Nasdaq 100 | 2.742% |
| iShares Nikkei 225® | 6.584% |
| iShares S&P 500 | 1.930% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.85
28.04.23
28.04.23
€21.78
28.04.24
28.04.24
28.81%
29.04.24
29.04.24
